In a recent SEC filing, MiNK Therapeutics, Inc., a biopharmaceutical company, declared the implementation of a reverse stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback